Drugs / i-FactorTM
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03112122 | Mar 2016 → Dec 2017 | bone marrow disorder | Rizzoli Orthopaedic Institute | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | i-FactorTM | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03112122 ↗ |
| Modality | Other / unclassified | “bone substitute i-FactorTM” NCT03112122 ↗ |
| Route | Other | “subchondral injections of i-FactorTM” NCT03112122 ↗ |